Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
3.120
-0.230 (-6.87%)
At close: Sep 26, 2025, 4:00 PM EDT
3.270
+0.150 (4.81%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $23.41 million as of September 26, 2025. Its market cap has increased by 126.44% in one year.
Market Cap
23.41M
Enterprise Value
30.59M
1-Year Change
126.44%
Ranking
Category
Stock Price
$3.12
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $23.41M, a decrease of -77.38%. That is a compound annual growth rate of -26.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 23.41M | -7.33% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | 104.41M | 0.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |